Banks - Regional
Compare Stocks
4 / 10Stock Comparison
LARK vs IROQ vs NECB vs CZWI
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
LARK vs IROQ vs NECB vs CZWI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $171M | $89M | $339M | $203M |
| Revenue (TTM) | $96M | $48M | $157M | $90M |
| Net Income (TTM) | $19M | $5M | $44M | $14M |
| Gross Margin | 71.2% | 54.7% | 66.1% | 54.7% |
| Operating Margin | 24.0% | 12.2% | 39.6% | 7.0% |
| Forward P/E | 9.1x | 19.4x | 7.6x | 11.8x |
| Total Debt | $34M | $73M | $75M | $52M |
| Cash & Equiv. | $21M | $20M | $81M | $119M |
LARK vs IROQ vs NECB vs CZWI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Landmark Bancorp, I… (LARK) | 100 | 143.0 | +43.0% |
| IF Bancorp, Inc. (IROQ) | 100 | 173.5 | +73.5% |
| Northeast Community… (NECB) | 100 | 424.0 | +324.0% |
| Citizens Community … (CZWI) | 100 | 286.8 | +186.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LARK vs IROQ vs NECB vs CZWI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LARK is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 8.3%, EPS growth 35.8%
- Lower volatility, beta 0.45, Low D/E 21.0%, current ratio 1.01x
- Beta 0.45, yield 2.8%, current ratio 1.01x
- 8.3% NII/revenue growth vs CZWI's -9.4%
IROQ is the clearest fit if your priority is stability.
- Beta 0.04 vs NECB's 0.83
NECB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.83, yield 4.0%
- 460.8% 10Y total return vs CZWI's 157.0%
- PEG 0.23 vs CZWI's 2.32
- NIM 4.9% vs IROQ's 2.3%
CZWI is the clearest fit if your priority is momentum.
- +45.6% vs LARK's -0.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.3% NII/revenue growth vs CZWI's -9.4% | |
| Value | Lower P/E (7.6x vs 11.8x), PEG 0.23 vs 2.32 | |
| Quality / Margins | Efficiency ratio 0.3% vs CZWI's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.04 vs NECB's 0.83 | |
| Dividends | 4.0% yield, 2-year raise streak, vs CZWI's 1.8% | |
| Momentum (1Y) | +45.6% vs LARK's -0.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CZWI's 0.5% |
LARK vs IROQ vs NECB vs CZWI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
LARK vs IROQ vs NECB vs CZWI — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NECB leads in 3 of 6 categories
CZWI leads 1 • LARK leads 0 • IROQ leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NECB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NECB is the larger business by revenue, generating $157M annually — 3.3x IROQ's $48M. NECB is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to IROQ's 8.9%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $96M | $48M | $157M | $90M |
| EBITDAEarnings before interest/tax | $25M | $7M | $63M | $9M |
| Net IncomeAfter-tax profit | $19M | $5M | $44M | $14M |
| Free Cash FlowCash after capex | $21M | $4M | $51M | $11M |
| Gross MarginGross profit ÷ Revenue | +71.2% | +54.7% | +66.1% | +54.7% |
| Operating MarginEBIT ÷ Revenue | +24.0% | +12.2% | +39.6% | +7.0% |
| Net MarginNet income ÷ Revenue | +19.6% | +8.9% | +28.2% | +16.0% |
| FCF MarginFCF ÷ Revenue | +21.9% | +13.5% | +32.3% | +11.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +35.1% | +115.0% | +6.8% | +63.0% |
Valuation Metrics
NECB leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 7.5x trailing earnings, NECB trades at a 61% valuation discount to IROQ's 19.4x P/E. Adjusting for growth (PEG ratio), NECB offers better value at 0.22x vs CZWI's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $171M | $89M | $339M | $203M |
| Enterprise ValueMkt cap + debt − cash | $184M | $142M | $333M | $136M |
| Trailing P/EPrice ÷ TTM EPS | 9.13x | 19.38x | 7.54x | 14.44x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 7.62x | 11.78x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.22x | 2.85x |
| EV / EBITDAEnterprise value multiple | 7.96x | 21.69x | 5.25x | 15.28x |
| Price / SalesMarket cap ÷ Revenue | 1.78x | 1.84x | 2.15x | 2.25x |
| Price / BookPrice ÷ Book value/share | 1.07x | 1.02x | 0.95x | 1.09x |
| Price / FCFMarket cap ÷ FCF | 8.13x | 13.65x | 6.67x | 19.55x |
Profitability & Efficiency
NECB leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
NECB delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $6 for IROQ. LARK carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to IROQ's 0.89x. On the Piotroski fundamental quality scale (0–9), LARK scores 8/9 vs NECB's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +6.0% | +13.1% | +7.8% |
| ROA (TTM)Return on assets | +1.2% | +0.6% | +2.2% | +0.8% |
| ROICReturn on invested capital | +8.3% | +2.9% | +12.5% | +2.0% |
| ROCEReturn on capital employed | +3.1% | +3.9% | +16.2% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.21x | 0.89x | 0.21x | 0.28x |
| Net DebtTotal debt minus cash | $13M | $53M | -$6M | -$67M |
| Cash & Equiv.Liquid assets | $21M | $20M | $81M | $119M |
| Total DebtShort + long-term debt | $34M | $73M | $75M | $52M |
| Interest CoverageEBIT ÷ Interest expense | 0.91x | 0.26x | 1.17x | 0.16x |
Total Returns (Dividends Reinvested)
CZWI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NECB five years ago would be worth $22,024 today (with dividends reinvested), compared to $12,561 for IROQ. Over the past 12 months, CZWI leads with a +45.6% total return vs LARK's -0.5%. The 3-year compound annual growth rate (CAGR) favors CZWI at 37.5% vs LARK's 19.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +8.7% | -1.6% | +9.4% | +21.5% |
| 1-Year ReturnPast 12 months | -0.5% | +10.9% | +10.7% | +45.6% |
| 3-Year ReturnCumulative with dividends | +69.8% | +82.2% | +107.8% | +160.0% |
| 5-Year ReturnCumulative with dividends | +61.2% | +25.6% | +120.2% | +71.2% |
| 10-Year ReturnCumulative with dividends | +116.1% | +59.5% | +460.8% | +157.0% |
| CAGR (3Y)Annualised 3-year return | +19.3% | +22.1% | +27.6% | +37.5% |
Risk & Volatility
Evenly matched — IROQ and NECB each lead in 1 of 2 comparable metrics.
Risk & Volatility
IROQ is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than NECB's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NECB currently trades 95.7% from its 52-week high vs LARK's 91.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 0.04x | 0.83x | 0.46x |
| 52-Week HighHighest price in past year | $30.80 | $29.00 | $25.61 | $22.62 |
| 52-Week LowLowest price in past year | $23.43 | $23.21 | $19.27 | $12.83 |
| % of 52W HighCurrent price vs 52-week peak | +91.0% | +91.6% | +95.7% | +93.2% |
| RSI (14)Momentum oscillator 0–100 | 58.0 | 34.4 | 50.5 | 63.7 |
| Avg Volume (50D)Average daily shares traded | 7K | 44K | 36K | 40K |
Analyst Outlook
Evenly matched — NECB and CZWI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NECB as "Hold", CZWI as "Buy". For income investors, NECB offers the higher dividend yield at 3.98% vs IROQ's 1.54%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | — | — |
| # AnalystsCovering analysts | — | — | 1 | 2 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +1.5% | +4.0% | +1.8% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 2 | 7 |
| Dividend / ShareAnnual DPS | $0.79 | $0.41 | $0.98 | $0.37 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.5% | +3.1% |
NECB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CZWI leads in 1 (Total Returns). 2 tied.
LARK vs IROQ vs NECB vs CZWI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LARK or IROQ or NECB or CZWI a better buy right now?
For growth investors, Landmark Bancorp, Inc.
(LARK) is the stronger pick with 8. 3% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). Northeast Community Bancorp, Inc. (NECB) offers the better valuation at 7. 5x trailing P/E (7. 6x forward), making it the more compelling value choice. Analysts rate Citizens Community Bancorp, Inc. (CZWI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LARK or IROQ or NECB or CZWI?
On trailing P/E, Northeast Community Bancorp, Inc.
(NECB) is the cheapest at 7. 5x versus IF Bancorp, Inc. at 19. 4x. On forward P/E, Northeast Community Bancorp, Inc. is actually cheaper at 7. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Northeast Community Bancorp, Inc. wins at 0. 23x versus Citizens Community Bancorp, Inc. 's 2. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — LARK or IROQ or NECB or CZWI?
Over the past 5 years, Northeast Community Bancorp, Inc.
(NECB) delivered a total return of +120. 2%, compared to +25. 6% for IF Bancorp, Inc. (IROQ). Over 10 years, the gap is even starker: NECB returned +460. 8% versus IROQ's +59. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LARK or IROQ or NECB or CZWI?
By beta (market sensitivity over 5 years), IF Bancorp, Inc.
(IROQ) is the lower-risk stock at 0. 04β versus Northeast Community Bancorp, Inc. 's 0. 83β — meaning NECB is approximately 2255% more volatile than IROQ relative to the S&P 500. On balance sheet safety, Landmark Bancorp, Inc. (LARK) carries a lower debt/equity ratio of 21% versus 89% for IF Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LARK or IROQ or NECB or CZWI?
By revenue growth (latest reported year), Landmark Bancorp, Inc.
(LARK) is pulling ahead at 8. 3% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: IF Bancorp, Inc. grew EPS 140. 4% year-over-year, compared to -7. 7% for Northeast Community Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LARK or IROQ or NECB or CZWI?
Northeast Community Bancorp, Inc.
(NECB) is the more profitable company, earning 28. 2% net margin versus 8. 9% for IF Bancorp, Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NECB leads at 39. 6% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — LARK leads at 71. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LARK or IROQ or NECB or CZWI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Northeast Community Bancorp, Inc. (NECB) is the more undervalued stock at a PEG of 0. 23x versus Citizens Community Bancorp, Inc. 's 2. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Northeast Community Bancorp, Inc. (NECB) trades at 7. 6x forward P/E versus 11. 8x for Citizens Community Bancorp, Inc. — 4. 2x cheaper on a one-year earnings basis.
08Which pays a better dividend — LARK or IROQ or NECB or CZWI?
All stocks in this comparison pay dividends.
Northeast Community Bancorp, Inc. (NECB) offers the highest yield at 4. 0%, versus 1. 5% for IF Bancorp, Inc. (IROQ).
09Is LARK or IROQ or NECB or CZWI better for a retirement portfolio?
For long-horizon retirement investors, IF Bancorp, Inc.
(IROQ) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 04), 1. 5% yield). Both have compounded well over 10 years (IROQ: +59. 5%, NECB: +460. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LARK and IROQ and NECB and CZWI?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: LARK is a small-cap deep-value stock; IROQ is a small-cap quality compounder stock; NECB is a small-cap deep-value stock; CZWI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.